WaferGen Bio-systems to Participate in the Ladenburg Thalmann 2015 Healthcare Conference

FREMONT, Calif., Sept. 28, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) announced today that Rollie Carlson, President and CEO, will present a corporate update at the Ladenburg Thalmann 2015 Healthcare Conference in New York, NY on September 29, 2015.

The presentation will be webcast live and archived for 30 days on WaferGen's Investor Relations website at http://ir.wafergen.com.

About WaferGen

WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The single cell analysis platform is a revolutionary system which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing (NGS). The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries. 

For additional information, please see http://www.wafergen.com.

CONTACT: INVESTOR CONTACTS:

         LifeSci Advisors, LLC
         Brian Ritchie
         [email protected]

         WaferGen Bio-systems, Inc.
         Rollie Carlson
         [email protected]

You May Also Be Interested In

• Zcash Price Prediction: ZEC Eyes $1,000 After 48% Surge as AlphaPepe Emerges in the Top AI Crypto Coin Race
• Denver HVAC Startup Reaches 2,132 Jobs and 69 Employees in Year One
• Alibaba Group Announced Pricing of HK$80 Billion Placing of New Shares in Hong Kong